Twitter | Search | |
Search Refresh
🖤Cookie Spencer Dec 11
So GP brought round the ‘what do you want when you are at the end of life ’ form -Do not resuscitate etc ...it has plunged us into a bit of a low place which is a shame as it was all fairly stable this morning. Get me off this rollercoaster -it’s not any fun.
Reply Retweet Like
LIH_Luxembourg Dec 12
[LIH news] awarded to candidate Yahaya Abubakar Yabo to support training and mobility for his research project! Congratulations!
Reply Retweet Like
U-M Rogel Cancer Center Dec 12
"It’s inspiring to see how they prioritize things that are in their control, and stay optimistic while still being realistic," Dr. says of patient Kathy Bellmore and her husband Paul.
Reply Retweet Like
CarThera Dec 13
Improving drug delivery for brain tumor treatment - Scientists propose combining ultrasound with other techniques to improve drug transport into tumors via .
Reply Retweet Like
Neural Cell News 13h
Publication in | Computational modeling demonstrates that cells can survive spatial environmental challenges through exploratory adaptation.
Reply Retweet Like
Dr. Bill Timmer Dec 10
Sex is an important prognostic factor for glioblastoma but not non-glioblastoma. Interesting; we are (slowly) identifying biomarkers for improved GBM survival: MGMT and IDH status, and sex.
Reply Retweet Like
Adriana D. Benavides Dec 12
Replying to @CIR_AACR
Great paper on how factors in can affect immunotherapy!
Reply Retweet Like
Adriana D. Benavides Dec 12
Read about how targeting factors in can improve !
Reply Retweet Like
CarThera Dec 13
Some news about our collaboration with 👉 Ultrasound blasts potent drug into brain tumor
Reply Retweet Like
Johnny Farina Dec 13
Replying to @MelissaMBlank
My brother-in-law was just diagnosed with yesterday. Grade IV. We are in shock and terrified over what we are reading. I’m so sorry you have this too, Melissa. 😢
Reply Retweet Like
CancerStemCell News Dec 12
Industry news | Diffusion Pharmaceuticals presents data suggesting optimized TSC dosing regimen increases survival in newly diagnosed inoperable patients.
Reply Retweet Like
Guy Lipof - גיא Dec 9
Replying to @vovo1967
Thanks Gonda! I’ve never heard of with extracranial metastasis. Not sure .02% is quite Bigfoot material, especially considering the shunt and other circumstances.
Reply Retweet Like
Dr. Bill Timmer Dec 11
Worth Watching: Catherine Ivy discussing her role in moving brain cancer forward via Phase 0 trials through her foundation: Philanthropist Funds Personalized Research Program For Brain Cancer via .
Reply Retweet Like
David Langsam Dec 10
. GDC-0084 Joins ‘GBM Agile’ Multi-Drug Trial - subscribe to Biotech Daily
Reply Retweet Like
Malnati Brain Tumor Institute at Northwestern 20h
Ultrasound blasts potent drug into brain tumor
Reply Retweet Like
Şevin Turcan Dec 6
Join us for an engaging course on GBM at a beautiful location!
Reply Retweet Like
Melissa Blank Dec 8
I thought so too. They told me that most pts. are like John McCain. I am in such a different demographic, there just isn't any sense in scaring myself with horrifying data that doesn't apply to me
Reply Retweet Like
FooZools Dec 11
Jesse Johnston please share Jesse's battle against brain Jesse is a true warrior, a young mother and a beautiful soul.
Reply Retweet Like
Isaac Yang MD 36m
Reply Retweet Like
UK Health Radio™ 10h
The Brief with Peter Hofland on - Catherine Ivy, the Founder and President of , the largest non-government organization supporter of , including (GBM) research in the world.
Reply Retweet Like